Chemo only

Phase 3Small molecule

Chemo only is one of 10 small molecule programs targeting Patients With Locally Advanced Rectal Cancer. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Patients With Locally Advanced Rectal CancerNot yet recruiting

Patients With Locally Advanced Rectal CancerPhase 3

Not yet recruiting

Competition

Competitive Landscape

10 competitors in Patients With Locally Advanced Rectal Cancer

#DrugCompanyPhaseTrials

Eloxatin

Teva

Phase 3

7 2

Xeloda

EEngelhard Arzneimittel GmbH & Co.KG

Phase 3

9 3

Camptosar

Pfizer

Phase 2

2 4

Beyfortus

BeiGene

Phase 2

1 5

Experimental

Biogen

Phase 2

1 6

Epacadostat

Incyte

Phase 2

1 7

Capecitabine and Trastuzumab

FFudan University

Phase 2

1 8

FOLFOX Chemotherapy

WWashington University School of Medicine

Phase 3

2 9

Chemo only

WWan He

Phase 3

1 10

CAPOX Chemotherapy

SSun Yat-sen University

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2029

Phase 3Not yet recruiting

Patients With Locally Advanced Rectal Cancer

NCT06832917

Clinical

Trials by Indication[1]

Patients With Locally Advanced Rectal Cancer1 trial

Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)

Not yet recruiting·WWan He·Phase 3·NCT06832917·238 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Chemo only. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chemo only compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chemo only. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Wan He company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: WWan He

Chemo only

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2029

Trials by Indication[1]

Patients With Locally Advanced Rectal Cancer1 trial

References

Drug Info

Quick Facts

Related News